Next Article in Journal
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans
Next Article in Special Issue
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
Previous Article in Journal
Physico-Chemical and Light-Induced Properties of Quinoline Azo-dyes Polymers
Previous Article in Special Issue
The Role of Protein Tyrosine Phosphatases in Inflammasome Activation
Open AccessReview

Epigenetic Mechanisms of Inflammasome Regulation

Department of Experimental Medicine, University of Perugia, 06132 Perugia, Italy
Department of Surgical and Biomedical Sciences, Urology and Andrology Clinic, University of Perugia, 05100 Terni, Italy
Polo d’Innovazione di Genomica, Genetica e Biologia, 05100 Terni, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(16), 5758;
Received: 1 July 2020 / Revised: 5 August 2020 / Accepted: 8 August 2020 / Published: 11 August 2020
(This article belongs to the Special Issue Inflammasome)
The innate immune system represents the host’s first-line defense against pathogens, dead cells or environmental factors. One of the most important inflammatory pathways is represented by the activation of the NOD-like receptor (NLR) protein family. Some NLRs induce the assembly of large caspase-1-activating complexes called inflammasomes. Different types of inflammasomes have been identified that can respond to distinct bacterial, viral or fungal infections; sterile cell damage or other stressors, such as metabolic imbalances. Epigenetic regulation has been recently suggested to provide a complementary mechanism to control inflammasome activity. This regulation can be exerted through at least three main mechanisms, including CpG DNA methylation, histones post-translational modifications and noncoding RNA expression. The repression or promotion of expression of different inflammasomes (NLRP1, NLRP2, NLRP3, NLRP4, NLRP6, NLRP7, NLRP12 and AIM2) through epigenetic mechanisms determines the development of pathologies with variable severity. For example, our team recently explored the role of microRNAs (miRNAs) targeting and modulating the components of the inflammasome as potential biomarkers in bladder cancer and during therapy. This suggests that the epigenetic control of inflammasome-related genes could represent a potential target for further investigations of molecular mechanisms regulating inflammatory pathways. View Full-Text
Keywords: inflammasome; microRNA; epigenetic modifications inflammasome; microRNA; epigenetic modifications
Show Figures

Figure 1

MDPI and ACS Style

Poli, G.; Fabi, C.; Bellet, M.M.; Costantini, C.; Nunziangeli, L.; Romani, L.; Brancorsini, S. Epigenetic Mechanisms of Inflammasome Regulation. Int. J. Mol. Sci. 2020, 21, 5758.

AMA Style

Poli G, Fabi C, Bellet MM, Costantini C, Nunziangeli L, Romani L, Brancorsini S. Epigenetic Mechanisms of Inflammasome Regulation. International Journal of Molecular Sciences. 2020; 21(16):5758.

Chicago/Turabian Style

Poli, Giulia; Fabi, Consuelo; Bellet, Marina M.; Costantini, Claudio; Nunziangeli, Luisa; Romani, Luigina; Brancorsini, Stefano. 2020. "Epigenetic Mechanisms of Inflammasome Regulation" Int. J. Mol. Sci. 21, no. 16: 5758.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop